Researchers have developed an artificial intelligence platform to analyze potentially cancerous lesions in mammography scans to determine if a patient should receive an invasive biopsy. But unlike its many predecessors, the algorithm is interpretable, meaning it shows physicians exactly how it came to its conclusions.
Delphinus Medical Technologies, Inc. announces that the U.S. FDA has granted premarket approval of its SoftVue 3D Whole Breast Ultrasound Tomography System for use as an adjunct to digital mammography in the screening of asymptomatic women with dense breast tissue.
Humans still seem to be better than technology when it comes to the accuracy of spotting possible cases of breast cancer during screening, suggests a new study.
To alert healthcare providers and patients about the questionable quality of mammograms performed at a Maryland healthcare facility, the FDA issued the following statement.
Read More
3D mammography reduces the number of breast cancer cases diagnosed in the period between routine screenings, when compared with traditional mammography, according to a large study from Lund University in Sweden.
Read More
The foremost network of cancer centers in the U.S. is recommending that people wait to get certain imaging such as mammograms until four to six weeks after their final dose of their coronavirus vaccine—as long as the delay does not interfere with their healthcare.
Read More
A new study looking at U.S. mammography screening rates during the first five months of the pandemic found both a strong rebound in breast cancer screening rates and a concerning cumulative deficit in mammograms due to missed appointments, as well as uncovering disparities when looking at screening according to race.
Read More
According to a new study in the American Journal of Roentgenology, contrast-enhanced mammography showed concordance with MRI in women with newly diagnosed breast cancer and breast augmentation.
Read More